A tuberculosis vaccine routinely given to children in countries with high rates of that bacterial disease might be helping to reduce deaths from COVID-19, researchers reported on Thursday in the scientific journal Proceedings of the National Academy of Sciences.
After accounting for differences in factors that might affect vulnerability to the virus – such as income, education, health services and age distribution – the researchers found that countries with higher rates of Bacille Calmette-Guérin (BCG) vaccinations for tuberculosis had lower peak mortality rates from COVID-19.
A good example was Germany, which had different vaccine plans before East Germany and West Germany were unified in 1990, the researchers said. COVID-19 mortality rates among senior citizens are nearly three times higher in western Germany than in eastern Germany, where more older people received the vaccine as infants, they found. Study co-author Luis Escobar of Virginia Tech said in a press statement that BCG vaccines have been shown to protect against other viral respiratory illnesses. Escobar cautioned that the new findings are preliminary.